3fq9: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 3fq9 is ON HOLD | The entry 3fq9 is ON HOLD until sometime in the future | ||
Authors: Zhao, M., Wan, Z.L., Whittaker, L., Xu, B., Phillips, N., Katsoyannis, P., Whittaker, J., Weiss, M.A. | Authors: Zhao, M., Wan, Z.L., Whittaker, L., Xu, B., Phillips, N., Katsoyannis, P., Whittaker, J., Weiss, M.A. | ||
| Line 7: | Line 7: | ||
Description: Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications | Description: Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Apr 15 09:50:32 2009'' | ||
Revision as of 09:50, 15 April 2009
Unreleased structure
The entry 3fq9 is ON HOLD until sometime in the future
Authors: Zhao, M., Wan, Z.L., Whittaker, L., Xu, B., Phillips, N., Katsoyannis, P., Whittaker, J., Weiss, M.A.
Description: Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications
Page seeded by OCA on Wed Apr 15 09:50:32 2009